| | 1197958-12-5 Basic information More.. |
| Product Name: | AP26113 | | Synonyms: | 5-chloro-2-N-[4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl]-4-N-(2-dimethylphosphorylphenyl)pyrimidine-2,4-diamine;AP26113-ANALOG;(2-((5-Chloro-2-((4-(4-(dimethylamino)piperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)ami;AP26113;AP26113/AP-26113;5-chloro-N2-(4-(4-(diMethylaMino)piperidin-1-yl)-2-Methoxy-5-Methylphenyl)-N4-(2-(diMethylphosphoryl)phenyl)pyriMidine-2,4-diaMine;5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine;5-Chloro-N2-[4-[4-(diMethylaMino)-1-piperidinyl]-2-Methoxyphenyl]-N4-[2-(diMethylphosphinyl)phenyl] | | CAS: | 1197958-12-5 | | MF: | C26H34ClN6O2P | | MW: | 529.01 | | EINECS: | 234-394-2 | | Mol File: | 1197958-12-5.mol |  |
Use
AP26113 (also known as Brigatinib) is an investigated small molecule for targeted cancer therapy. It is a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). It is mainly under investigation for its treatmentefficacy on non-small cell lung cancer (NSCLC) where ALK is activated and EGFP mutations frequently occur.
- AP26113
-
- US $0.00-0.00 / g
- 2025-01-31
- CAS:1197958-12-5
- Min. Order: 1g
- Purity: 99% HPLC
- Supply Ability: 10000
- Brigatinib(ap26113)
-
- US $0.00 / g
- 2024-11-19
- CAS:1197958-12-5
- Min. Order: 1g
- Purity: 98% HPLC
- Supply Ability: 1kg
- AP26113
-
- US $0.00 / kg
- 2024-10-25
- CAS:1197958-12-5
- Min. Order: 1kg
- Purity: 0.99
- Supply Ability: 20tons
|
|
1197958-12-5
Recommend Suppliers |
|